DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Wickremaratchi M, Hadjikoutis S, Lambert P. et al.
A tolerability study of intranasal apomorphine powder (5 mg) in subjects with Parkinson's disease and motor fluctuations over a 7-day period: a phase two study.
Mov Disord 2002; 17, suppl 5: S103-S104
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.